Headland Ventures

What Headland Ventures does

Headland Ventures LP is a private venture partnership formed in 2002 and headquartered in San Rafael, California. The firm focuses exclusively on early stage company investing, having been established to continue the early stage investment activities previously conducted through Sterling Payot Company. Headland Management LLC serves as the General Partner, with Robert M. Smelick — a career investment banker whose background includes senior roles at Kidder Peabody and The First Boston Corporation — serving as CEO. Smelick co-founded Sterling Payot in 1989, where he made early stage investments in Yahoo, Packeteer, Agile Software, Wired Ventures, and Accrue Software during the 1990s.

The firm's portfolio consists of seven disclosed companies spanning biotechnology (Avid Biotics, Viamet Pharmaceuticals, Novocell), electronic materials (Cambrios), consumer food (TCHO), venture capital fund exposure (Hatteras Venture Partners), and VoIP infrastructure (New Cross Technologies). Headland does not publicly disclose fund size, AUM, fee structure, or management team beyond Smelick. The partnership's website displays a 2014 copyright and references additional investments not enumerated in third-party data, but no new investment activity, fund closes, or partnership additions have been documented since.

As a traditional venture partnership, Headland's revenue model relies on management fees (typically ~2% of committed capital) and carried interest on profitable portfolio exits. Deal sourcing is driven entirely by the personal network and reputation of its principals rather than conventional marketing or distribution channels. The firm has no disclosed employees beyond the named GP principal, no parent operating company, and no subsidiaries. There is no evidence of artificial intelligence or machine learning capabilities, proprietary technology platforms, or external integration partnerships beyond portfolio equity investments.

Name

Headland Ventures

Legal name

Headland Ventures LP

Website

https://headlandventures.com

Company type

Private

Founded year

2002

Operating status

Operating

Short description

Headland Ventures LP is a San Rafael, California venture partnership founded in 2002 that makes early stage equity investments in early-stage biotechnology, materials, consumer, and technology companies, operating as a continuation of Sterling Payot under CEO Robert M. Smelick.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Portfolio Management and Investment Advice (52394), Funds, Trusts, and Other Financial Vehicles (525)

SIC

Investment Advice (6282)

akta.pro primary industry

Venture Capital Fund-of-Funds (FSANAGAC)

akta.pro secondary industry

Emerging Manager / Seeding Platforms (Multi-Manager) (FSANAGAF)

Keywords

• Venture capital investing
• Early stage capital
• Corporate finance advisory
• Biotechnology investment
• Startup funding

Headquarters

HQ city

San Rafael

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Core offering

Headland Ventures LP is a venture partnership that invests early stage capital in entrepreneurial companies across biotechnology, life sciences, display technology, consumer products, and telecommunications. The General Partner, Headland Management LLC, also advises the partnership's investors on other financial matters. The firm continues the early stage investment activities originally pursued by Sterling Payot Company.

Product overview

Headland Ventures LP is a venture partnership focused on early stage company investing. The General Partner is Headland Management LLC, led by CEO Robert M. Smelick. The firm continues the early stage investment activities of Sterling Payot Company investors. The investment portfolio spans biotechnology (Avid Biotics, Viamet Pharmaceuticals, Novocell), electronic materials (Cambrios), consumer products (TCHO), venture capital (Hatteras Venture Partners), and telecommunications technology (New Cross Technologies).

Differentiator

Problem solved

Functional benefit

Products and services

• Headland Ventures LP Early Stage Investment Partnership

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves1 record

Expansion highlights2 records

Direct peers

• Avalon Ventures: San Diego-based early-stage venture firm with a comparable mix of biotech, deep tech, and tech seed investments, run by a small principal-led team. Avalon is the most structurally similar peer — a small, principal-driven West Coast partnership investing across multiple frontier technology verticals.
• ARCH Venture Partners: Long-tenured early-stage deep-tech and biotech investor with multi-manager LP relationships and a portfolio that mirrors Headland's heavy weighting toward proprietary-platform life sciences and advanced materials. ARCH represents the institutional-scale analog of Headland's biotech-heavy thesis.
• Versant Ventures: Healthcare-dedicated early-stage VC with deep biotech, pharma, and medical-device exposure — closely matching Headland's Avid Biotics / Viamet / Novocell cluster. Versant is a directly comparable peer in the biotech-seed segment of Headland's portfolio.
• Mission Bay Capital: San Francisco-based early-stage investor founded by former QB3 biotech operators, with a comparable mix of biotech seed and adjacent tech deals. Mission Bay is one of the closest geographic and stage peers to Headland in the Bay Area.
• InterWest Partners: Earlier-stage life sciences and technology partnership with a similar West Coast footprint and biotech/tech portfolio mix. InterWest is comparable to Headland in vintage continuity and principal-driven structure.
• Latterell Venture Partners: Small, principal-led early-stage partnership based in California that has historically invested across a similarly diversified set of verticals including biotech, healthcare, and technology. Structurally analogous to Headland in fund size and decision-making model.
• Sanderling Ventures: Early-stage biotech and biomedical investor operating out of California with a comparable small-fund, principal-led structure and similar portfolio focus on therapeutics and platform biotech companies analogous to Headland's life sciences bets.
• OVP Venture Partners: Long-running Pacific Northwest early-stage VC with a similarly small, principal-driven model and thematic flexibility across hardware, biotech, and software — closely mirroring Headland's sector-spanning seed approach and vintage continuity.
• Bay City Capital: San Francisco-based life-sciences-focused venture firm investing across therapeutics, diagnostics, and medical devices — directly comparable to the biotech/pharma portion of Headland's portfolio (Avid Biotics, Viamet, Novocell).

Broad incumbents

• Kleiner Perkins: Large, established multi-stage West Coast venture firm with overlapping biotech, materials, and consumer portfolio exposures. Kleiner Perkins represents the broad-incumbent counterpoint to Headland — same geographic and sector adjacency, but at materially greater scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Headland Ventures